JMS Co Ltd operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JMS Co Ltd with three other
companies in this sector in Japan:
Kawasumi Laboratories, Incorporated
sales of 28.14 billion Japanese Yen [US$271.50 million]
of which 52%
was Extracorporeal Circulation-Related),
Asahi Intecc Co., Ltd.
(39.51 billion Japanese Yen [US$381.28 million]
of which 79%
was Medical), and
(16.56 billion Japanese Yen [US$159.76 million]
JMS Co Ltd reported sales of ¥57.64 billion (US$556.19 million)
March of 2016.
increase of 4.0%
versus 2015, when the company's sales were ¥55.40 billion.
Sales at JMS Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 26%).
Sales of Operating Segment-America saw an increase
that was more than double the company's growth rate: sales were up
10.7% in 2016, from
¥2.83 billion to ¥3.13 billion.
JMS Co Ltd also saw significant increases in sales in
Operating Segment-Southeast Asia (up 8.6% to ¥10.39 billion)
Operating Segment-China (up 7.9% to ¥1.69 billion)
Not all segments of JMS Co Ltd experienced an increase in sales in 2016:
sales of Operating Segment-Germany fell 2.4% to ¥3.32 billion.